Cardiovascular Protective Effects of On-Line Hemodiafiltration: Comparison With Conventional Hemodialysis

Therapeutic Apheresis and Dialysis

Volumn 16, Issue 2, 2012, Pages 181-188

  Ohtake, Takayasu ^a   Oka, Machiko ^a   Ishioka, Kunihiro ^a   Honda, Kenjiro ^a   Mochida, Yasuhiro ^a   Maesato, Kyoko ^a   Moriya, Hidekazu ^a   Hidaka, Sumi ^a   Kobayashi, Shuzo ^a  

^a SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Brachial ankle pulse wave velocity; Hemodialysis; Left ventricular mass index; On line hemodiafiltration

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE;

ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BRACHIAL ARTERY; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 84859161072     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.01042.x     Document Type: Article

References (33)

1. Hemmelgarn BR, Southern D, Culleton BF etal. Survival after coronary revascularization among patients with kidney disease. Circulation 2004;110:1890-5.
2. Herzog CA. Poor long-term survival of dialysis patients after acute myocardial infarction: bad treatment or bad disease? Am J Kidney Dis 2000;35:1217-20.
3. Ohtake T, Ishioka K, Honda K etal. Impact of coronary artery calcification in hemodialysis patients: risk factors and associations with prognosis. Hemodial Int 2010;14:218-25.
4. Matsuoka M, Iseki K, Tamashiro M etal. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004;8:54-8.
5. Sozio SM, Armstrong PA, Coresh J etal. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis 2009;54:468-77.
6. O'Hare AM, Bertenthal D, Shipak MG etal. Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 2005;16:514-19.
7. Rajagopalan S, Dellegrottaglie S, Furniss AL etal. Peripheral arterial disease in patients with renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 2006;114:1914-22.
8. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
9. Canaud B, N'Guyen QV, Lagarde C etal. Clinical evaluation of a multipurpose dialysis system adequate for hemodialysis or for postdilution hemofiltration/hemodiafiltration with on-line preparation of substitution fluid from dialysate. Contrib Nephrol 1985;46:184-6.
10. Altieri P, Sorba G, Bolasco P etal. Comparison between hemofiltration and hemodiafiltration in a long-term prospective cross-over study. J Nephrol 2004;17:414-22.
11. Locatelli F, Altieri P, Andrulli S etal. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol 2010;21:1798-807.
12. Vaslaki L, Major L, Berta K etal. On-line hemodiafiltration versus hemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006;24:163-73.
13. Lin CL, Huang CC, Chang CT etal. Clinical improvement by increased frequency of on-line hemodiafiltration. Ren Fail 2001;23:193-206.
14. Lornoy W, Becaus I, Billiouw JM etal. On-line hemodiafiltration. Remarkable removal of beta 2 microglobulin. Long term clinical observations. Nephrol Dial Transplant 2000;15(Suppl 1):49-54.
15. Pizzarelli F, Cerrai T, Dattolo P, Tetta C, Maggiore Q. Convective treatments with on-line production of replacement fluid: a clinical experience lasting 6years. Nephrol Dial Transplant 1998;13:363-9.
16. Zocccali C, Benedetto FA, Mallamaci F etal. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertropthy progression. Kidney Int 2004;65:1492-8.
17. Blacher J, Guerin AP, Pannier B etal. Impact of aoirtic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-9.
18. Ono K, Tsuchida A, Kawai H etal. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 2003;14:1591-8.
19. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 2001;12:2458-64.
20. Gardin JM, Adams DB, Douglas PS etal. Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr 2002;15:275-90.
21. Kobayshi S, Moriya H, Aso K, Ohtake T. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int 2003;63:1881-7.
22. Toussaint ND, Lau KK, Strauss BJ etal. Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross sectional study of prevalent Australian hemodialysis patients. Nephrology 2009;14:105-12.
23. Moriya H, Ohtake T, Kobayashi S. Aortic stiffness, left ventricular hypertrophy and weekly averaged blood pressure (WAB) in patients on hemodialysis. Nephrol Dial Transplant 2007;22:1198-204.
24. London GM, Marchais SJ, Guerin AP etal. Inflammation, atherosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int Suppl 2003;84:S88-93.
25. Kobayashi S, Miyamoto M, Kurumatani H etal. Increased leukocyte aggregates are associated with atherosclerosis in patients with hemodialysis. Hemodial Int 2009;13:286-92.
26. Matsumae T, Abe Y, Murakami G etal. Effects of glucose metabolism on aortic pulse wave velocity in hemodialysis patients with and without diabetes. Hypertens Res 2008;31:1365-72.
27. Kato A, Odamaki M, Ishida J, Hishida A. Association of high-molecular-weight to total adiponectin ratio with pulse wave velocity in hemodialysis patients. Nephron Clin Pract 2008;109:c18-c24.
28. Kutlay S, Dincer I, Sengul S etal. The long term behavior and predictors of left ventricular hypertrophy in hemodialysis patients. Am J Kidney Dis 2006;47:485-92.
29. Yildiz A, Hemisoglu E, Oflaz H etal. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic hemodialysis patients. Nephrol Dial Transplant 2005;20:760-7.
30. Gagliardi GM, Rossi S, Manes MT etal. Impact of left ventricular patterns and diastolic dysfunction on hemodialysis patients. G Ital Nefrol 2004;21:45-50.
31. Masakane I. Selection of dilutional method for on-line HDF, pre- or post-dilution. Blood Purif 2004;22(Suppl 2):49-54.
32. Fry AC, Singh DK, Chandra SM, Farrington K. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif 2007;25:295-302.
33. Penne EL, van der Weerd NC, Blankestijn PJ etal. Role of residual kidney function and convective volume on change in beta 2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol 2010;5:80-6.